Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
Top Cited Papers
Open Access
- 5 April 2012
- Vol. 61 (5) , 646-664
- https://doi.org/10.1136/gutjnl-2012-302084
Abstract
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.Keywords
This publication has 98 references indexed in Scilit:
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysisEuropean Journal of Human Genetics, 2009
- Dietary glycemic load and gastric cancer risk in ItalyBritish Journal of Cancer, 2009
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in MiceCancer Cell, 2008
- Exploring the cost‐effectiveness ofHelicobacter pyloriscreening to prevent gastric cancer in China in anticipation of clinical trial resultsInternational Journal of Cancer, 2008
- Hereditary Diffuse Gastric Cancer: Prophylactic Surgical Oncology ImplicationsSurgical Clinics of North America, 2008
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008
- Family history of cancer and stomach cancer riskInternational Journal of Cancer, 2008
- Gastric cancer screening using the serum pepsinogen test methodGastric Cancer, 2006
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993